Torcetrapib does not reduce atherosclerosis beyond atorvastatin and induces more proinflammatory lesions than atorvastatin.

Autor: de Haan W, de Vries-van der Weij J, van der Hoorn JWA, Gautier T, van der Hoogt CC, Westerterp M, Romijn JA, Jukema JW, Havekes LM, Princen HMG, Rensen PCN
Zdroj: Circulation; 5/13/2008, Vol. 117 Issue 19, p2515-2522, 8p
Databáze: Complementary Index